Here are four facts:
1. The credit rating indicates the company is a moderate default risk.
2. Morningstar also gave Zimmer Biomet stock a four-star rating.
3. Zimmer Biomet has a 50-day moving average of $100.96 and a 200-day moving average of $109.45.
4. The company has a market cap of $19.07 billion and a P/E ratio of 47.61.
More articles on devices:
Materialise, Lima partner on total knee replacements: 5 things to know
MedTorque releases new handle ratcheting for orthopedics, spine: 5 things to know
K2M commercially launches deformity spinal system in the US: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.